Vicore Pharma Holding AB (publ) 6Y4.F Stock
Vicore Pharma Holding AB (publ) Price Chart
Vicore Pharma Holding AB (publ) 6Y4.F Financial and Trading Overview
| Vicore Pharma Holding AB (publ) stock price | 1.51 EUR |
| Previous Close | 1.58 EUR |
| Open | 1.58 EUR |
| Bid | 1.54 EUR x N/A |
| Ask | 1.57 EUR x N/A |
| Day's Range | 1.58 - 1.58 EUR |
| 52 Week Range | 1.22 - 3.2 EUR |
| Volume | 700 EUR |
| Avg. Volume | 99 EUR |
| Market Cap | 128.99M EUR |
| Beta (5Y Monthly) | 0.582758 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.28 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6Y4.F Valuation Measures
| Enterprise Value | 129.65M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.26820967 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Vicore Pharma Holding AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.582758 |
| 52-Week Change | -42.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.2 EUR |
| 52 Week Low | 1.22 EUR |
| 50-Day Moving Average | 1.74 EUR |
| 200-Day Moving Average | 1.95 EUR |
6Y4.F Share Statistics
| Avg. Volume (3 month) | 99 EUR |
| Avg. Daily Volume (10-Days) | 70 EUR |
| Shares Outstanding | 81.85M |
| Float | 49.77M |
| Short Ratio | N/A |
| % Held by Insiders | 16.76% |
| % Held by Institutions | 59.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.0059% |
| Return on Equity (ttm) | -101.32% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.288 |
| Book Value Per Share (mrq) | 5.876 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Vicore Pharma Holding AB (publ)
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | Kornhamnstorg 53 |
| ZIP | SE-111 27 |
| Phone | 46 31 788 05 60 |
| Website | https://www.vicorepharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 25 |
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company's portfolio includes idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) diseases. The company develops C21, a low molecular weight angiotensin II type 2 receptor agonist ATRAG; Almee, an investigational medical device in clinical development to address the psychological impact of living with pulmonary fibrosis; Inhaled IMID for the severe cough associated with IPF; and C103, C111, and C112. It has a collaboration and development agreement with Emeriti Bio AB. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is based in Stockholm, Sweden.
Q&A For Vicore Pharma Holding AB (publ) Stock
What is a current 6Y4.F stock price?
Vicore Pharma Holding AB (publ) 6Y4.F stock price today per share is 1.51 EUR.
How to purchase Vicore Pharma Holding AB (publ) stock?
You can buy 6Y4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vicore Pharma Holding AB (publ)?
The stock symbol or ticker of Vicore Pharma Holding AB (publ) is 6Y4.F.
Which industry does the Vicore Pharma Holding AB (publ) company belong to?
The Vicore Pharma Holding AB (publ) industry is Biotechnology.
How many shares does Vicore Pharma Holding AB (publ) have in circulation?
The max supply of Vicore Pharma Holding AB (publ) shares is 112.83M.
What is Vicore Pharma Holding AB (publ) Price to Earnings Ratio (PE Ratio)?
Vicore Pharma Holding AB (publ) PE Ratio is now.
What was Vicore Pharma Holding AB (publ) earnings per share over the trailing 12 months (TTM)?
Vicore Pharma Holding AB (publ) EPS is -0.28 EUR over the trailing 12 months.
Which sector does the Vicore Pharma Holding AB (publ) company belong to?
The Vicore Pharma Holding AB (publ) sector is Healthcare.